Bristol-Myers Squibb (BMY) Tops Q4 EPS by 9c, Offers FY19 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads gains as SpaceX, Super Micro results improve AI appetite
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $60.99 -1.12%
Revenue Growth %: +4.3%
Financial Fact:
Earnings Before Income Taxes: 1.56B
Today's EPS Names:
OMID, BCML, CZNC, More
Revenue Growth %: +4.3%
Financial Fact:
Earnings Before Income Taxes: 1.56B
Today's EPS Names:
OMID, BCML, CZNC, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q4 EPS of $0.94, $0.09 better than the analyst estimate of $0.85. Revenue for the quarter came in at $5.97 billion versus the consensus estimate of $5.99 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2019 EPS of $4.10-$4.20, versus the consensus of $4.14.
- Worldwide revenues increasing in the mid-single digits.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix shares fall over 5% premarket on soft current-quarter revenue guidance
- Abbott (ABT) Reports In-Line Q3 EPS
- Moody's Corp. (MCO) Misses Q3 EPS by 11c; offers guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
